M.Sc. candidate The Hebrew University of Jerusalem, Israel
Introduction: Digital Light Processing (DLP) 3D printing offers high-resolution capabilities essential for personalized medicine, yet is limited by a scarcity of biocompatible resins. Furthermore, the emergence of 4D printing allows for the creation of smart devices that respond to stimuli. This study addresses these challenges by developing a library of novel bioinks based on Poly(ethylene glycol) diacrylate (PEGDA) and Methacrylated Carboxymethyl Cellulose (M-CMC), aiming to create a versatile platform for fabricating tunable, drug-eluting hydrogels.
Learning Objectives:
Identify key parameters for optimizing biocompatible photo-resins for DLP 3D printing.
Demonstrate the ability to tune mechanical stiffness and hydrophilicity in printed hydrogels.
Evaluate the potential of PEGDA and M-CMC bioinks for controlled drug delivery applications.
